See more : TS Wonders Holding Limited (1767.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Kenvue Inc. (KVUE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kenvue Inc., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Texas Pacific Land Corporation (TPL) Income Statement Analysis – Financial Results
- Daewoong Co., Ltd. (003090.KS) Income Statement Analysis – Financial Results
- Amundi S.A. (AMDUF) Income Statement Analysis – Financial Results
- Tronic’s Microsystems SA (ALTRO.PA) Income Statement Analysis – Financial Results
- Tokyo Rakutenchi Co.,Ltd. (8842.T) Income Statement Analysis – Financial Results
Kenvue Inc. (KVUE)
About Kenvue Inc.
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 15.44B | 14.95B | 15.05B | 14.47B | 14.32B |
Cost of Revenue | 6.80B | 6.67B | 6.64B | 6.62B | 6.66B |
Gross Profit | 8.64B | 8.29B | 8.42B | 7.85B | 7.66B |
Gross Profit Ratio | 55.96% | 55.42% | 55.93% | 54.25% | 53.49% |
Research & Development | 399.00M | 375.00M | 355.00M | 320.00M | 391.00M |
General & Administrative | 4.33B | 4.28B | 4.02B | 3.73B | 3.94B |
Selling & Marketing | 1.35B | 1.36B | 1.46B | 1.23B | 1.26B |
SG&A | 5.68B | 5.63B | 5.48B | 4.96B | 5.20B |
Other Expenses | 50.00M | 4.00M | 25.00M | 3.00M | 59.00M |
Operating Expenses | 6.13B | 5.62B | 5.41B | 4.86B | 5.26B |
Cost & Expenses | 12.93B | 12.28B | 12.04B | 11.48B | 11.93B |
Interest Income | 108.00M | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 358.00M | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 627.00M | 644.00M | 731.00M | 746.00M | 709.00M |
EBITDA | 3.18B | 3.64B | 3.87B | 3.79B | 3.28B |
EBITDA Ratio | 20.56% | 22.39% | 25.61% | 53.51% | 25.98% |
Operating Income | 2.51B | 2.68B | 2.92B | -979.00M | 1.85B |
Operating Income Ratio | 16.27% | 17.89% | 19.40% | -6.77% | 12.89% |
Total Other Income/Expenses | -322.00M | -38.00M | 5.00M | -37.00M | 274.00M |
Income Before Tax | 2.19B | 2.64B | 2.93B | -1.02B | 2.12B |
Income Before Tax Ratio | 14.18% | 17.64% | 19.43% | -7.02% | 14.80% |
Income Tax Expense | 526.00M | 550.00M | 894.00M | -137.00M | 685.00M |
Net Income | 1.66B | 2.06B | 2.08B | -879.00M | 1.44B |
Net Income Ratio | 10.77% | 13.81% | 13.80% | -6.08% | 10.02% |
EPS | 0.90 | 1.08 | 1.08 | -0.47 | 0.76 |
EPS Diluted | 0.87 | 1.08 | 1.08 | -0.47 | 0.76 |
Weighted Avg Shares Out | 1.85B | 1.91B | 1.89B | 1.89B | 1.89B |
Weighted Avg Shares Out (Dil) | 1.92B | 1.91B | 1.89B | 1.89B | 1.89B |
5 Dividend Kings Provide Perfect Passive Income Streams for Retirement
Worried About a Stock Market Sell-Off? Consider Coca-Cola, Pepsi, and These 3 Safe Dividend Kings for Decades of Passive Income.
Kenvue Announces Participation in the Barclays Global Consumer Staples Conference
Passive Income Matters: These 3 Stocks Are Perennial Dividend Growers Worth Buying
Lock in Gains: 3 Dividend Stocks Poised to Boost Payouts Soon
Kenvue Introduces Patented Micro-Peptide Technology with Neutrogena® Collagen Bank™ Launch
Buy These 5 Dividend Kings in August for Years of Passive Income
7 Stable Dividend Stocks to Scoop Up on Discount
Kenvue: Promising Steps Toward Long-Term Success
Prediction: These 3 Dividend Stocks Will Pay More in Dividends in 2025
Source: https://incomestatements.info
Category: Stock Reports